Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3779/j.issn.1009-3419.2020.03.02 http://scihub22266oqcxt.onion/10.3779/j.issn.1009-3419.2020.03.02 32077441!7118333!32077441     free     free     free Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538 Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32077441.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Zhongguo+Fei+Ai+Za+Zhi 2020 ; 23 (3): 136-141 Nephropedia Template TP {{tp|p=32077441|t=2020. Clinical Management of Lung Cancer Patients during the Outbreak of 2019 Novel Coronavirus Disease (COVID-19) |pdf=|usr=}}{{32077441}} gab.com Text Clinical Management of Lung Cancer Patients during the Outbreak of 2019 Novel Coronavirus Disease (COVID-19) JO: Zhongguo Fei Ai Za Zhi http://www.kidney.de/pget.php?&tw=1&pmid=32077441 #FOAvip Since late December 2019, an outbreak of 2019 novel coronavirus diseases (COVID-19) in Wuhan, China has spread quickly nationwide. With the spread of COVID-19, the routine clinical diagnosis and treatment for lung cancer patients has been disturbed. Due to the systemic immunosuppressive of lung cancer patients caused by the malignancy and anticancer treatments, lung cancer patients are more susceptible to infection than healthy individuals. Furthermore, patients with cancer had poorer prognosis from infection. Lung cancer patients should be the priority group for COVID-19 prevention. The protection provisions and control measures aiming to protect lung cancer patients from COVID-19 have been increasingly concerned. During the COVID-19 outbreak period, it should be carefully differentiated for fever and respiratory symptoms for lung cancer patients receiving anti-tumor treatment, in order to evaluate the risk of COVID-19. Moreover, it is necessary to carry out meticulous and individualized clinical management for lung cancer patients to effectively protect the patients from COVID-19. Twit Text FOAVip Clinical Management of Lung Cancer Patients during the Outbreak of 2019 Novel Coronavirus Disease (COVID-19) ????Zhongguo Fei Ai Za Zhi http://www.kidney.de/pget.php?&tw=1&pmid=32077441 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32077441 #FOAvip English Wikipedia <ref>{{Cite pmid|32077441}}</ref> Clinical Management of Lung Cancer Patients during the Outbreak of 2019 Novel Coronavirus Disease (COVID-19) #MMPMID32077441 Xu Y; Liu H; Hu K; Wang M Zhongguo Fei Ai Za Zhi 2020[Mar]; 23 (3): 136-141 PMID32077441show ga Since late December 2019, an outbreak of 2019 novel coronavirus diseases (COVID-19) in Wuhan, China has spread quickly nationwide. With the spread of COVID-19, the routine clinical diagnosis and treatment for lung cancer patients has been disturbed. Due to the systemic immunosuppressive of lung cancer patients caused by the malignancy and anticancer treatments, lung cancer patients are more susceptible to infection than healthy individuals. Furthermore, patients with cancer had poorer prognosis from infection. Lung cancer patients should be the priority group for COVID-19 prevention. The protection provisions and control measures aiming to protect lung cancer patients from COVID-19 have been increasingly concerned. During the COVID-19 outbreak period, it should be carefully differentiated for fever and respiratory symptoms for lung cancer patients receiving anti-tumor treatment, in order to evaluate the risk of COVID-19. Moreover, it is necessary to carry out meticulous and individualized clinical management for lung cancer patients to effectively protect the patients from COVID-19. |*Betacoronavirus/pathogenicity[MESH] |*Coronavirus Infections/epidemiology[MESH] |*Disease Outbreaks[MESH] |*Immunocompromised Host[MESH] |*Lung Neoplasms/diagnosis/therapy[MESH] |*Pneumonia, Viral/epidemiology[MESH] |COVID-19[MESH] |China[MESH] |Disease Susceptibility[MESH] |Humans[MESH] |Patient Care Planning[MESH] |Risk[MESH] Clinical Management of Lung Cancer Patients during the Outbreak of 20(epmc).pdf DeepDyve Pubget Overpricing